Biosig Technologies, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
Avanico Limited and Frank Giustra have filed an amended Schedule 13G, correcting previously reported beneficial ownership in Streamex Corp. to 12.02%.
Avanico Limited and Frank Giustra have disclosed a 12.13% beneficial ownership stake in BioSig Technologies, Inc., primarily through exchangeable shares contingent on future stockholder approval.